Ujjwal Ramtekkar - 06 Mar 2025 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief Medical Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
06 Mar 2025
Net transactions value
-$49,669
Form type
4
Filing time
10 Mar 2025, 20:46:27 UTC
Previous filing
12 Mar 2024
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +57,107 +91% $0.000000 119,520 06 Mar 2025 Direct F1
transaction LFST Common Stock Award $0 +20,805 +17% $0.000000 140,325 07 Mar 2025 Direct F2
transaction LFST Common Stock Tax liability $49,669 -6,544 -4.7% $7.59 133,781 07 Mar 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 57,107 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.
F3 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.